Optetrak Knee System Post Market Clinical Follow-Up

Sponsor
Exactech (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05788757
Collaborator
(none)
8,000
3
276
2666.7
9.7

Study Details

Study Description

Brief Summary

A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System

Condition or Disease Intervention/Treatment Phase
  • Device: Optetrak Total Knee System

Detailed Description

Patient outcomes data is important for assessing the post-market safety and effectiveness of orthopedic medical devices. The purpose of this study is to collect clinical and patient outcomes and survivorship data for patients who have received or will receive a Optetrak® knee prosthesis manufactured or distributed by Exactech Inc (Gainesville, Florida, USA).

Study Design

Study Type:
Observational
Anticipated Enrollment :
8000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Actual Study Start Date :
Jun 1, 2011
Anticipated Primary Completion Date :
Dec 31, 2033
Anticipated Study Completion Date :
Jun 1, 2034

Arms and Interventions

Arm Intervention/Treatment
Enrolled Subjects

Patients recruited from the population undergoing knee arthroplasty as part of standard of care. Patients who meet all the inclusion criteria and none of the exclusion criteria should be presented with an opportunity to undergo the informed consent process.

Device: Optetrak Total Knee System
Total Knee Arthroplasty using Exactech's Optetrak branded components.

Outcome Measures

Primary Outcome Measures

  1. Knee Society Score [Preoperative]

    (KSS) - validated outcome score

  2. Knee Society Score [6 month postoperative]

    (KSS) - validated outcome score

  3. Knee Society Score [annually through study completion, maximum of 10-years]

    (KSS) - validated outcome score

  4. Hospital for Special Surgery Knee Score [Preoperative]

    (HSS) - validated outcome score

  5. Hospital for Special Surgery Knee Score [6 month postoperative]

    (HSS) - validated outcome score

  6. Hospital for Special Surgery Knee Score [annually through study completion, maximum of 10-years]

    (HSS) - validated outcome score

  7. Oxford Knee Score [Preoperative]

    (OKS) - validated outcome score

  8. Oxford Knee Score [6 month postoperative]

    (OKS) - validated outcome score

  9. Oxford Knee Score [annually through study completion, maximum of 10-years]

    (OKS) - validated outcome score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patient is indicated for knee replacement, or has already undergone knee replacement, with a device manufactured or distributed by Exactech

  • Patient is skeletally mature

  • Patient meets the indications detailed in the applicable product package insert Patient is willing and able to review and sign an informed consent form, if necessary

Exclusion Criteria:
  • Patient has a local or systemic infection

  • Patient has a known sensitivity to one or more of the materials in the knee replacement system to be used

  • Patient is pregnant

  • Patient has a mental or physical condition that may invalidate evaluation of the data


  • Patient is a prisoner

  • Surgery is contraindicated according to the applicable product package insert

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fallon Clinic Worcester Massachusetts United States 01608
2 Nevada Orthopaedic and Spine Center Las Vegas Nevada United States 89128
3 Medical University South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Exactech

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Exactech
ClinicalTrials.gov Identifier:
NCT05788757
Other Study ID Numbers:
  • CR05-007
First Posted:
Mar 29, 2023
Last Update Posted:
Mar 29, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Mar 29, 2023